Literature DB >> 25772633

A Novel Electrocardiographic T-Wave Measurement (Tp-Te Interval) as a Predictor of Heart Abnormalities in Hypertension: A New Opportunity for First-Line Electrocardiographic Evaluation.

Andrea Ferrucci1, Flaminia Canichella1, Allegra Battistoni1, Francesca Palano1, Pietro Francia1, Giuseppino Massimo Ciavarella1, Massimo Volpe1,2, Giuliano Tocci1,2.   

Abstract

The aim of the study was to evaluate the role of conventional and new markers of early cardiac organ damage (OD) on 12-lead electrocardiography (ECG) in 25 outpatients with newly diagnosed untreated essential hypertension compared with 15 normotensive, otherwise healthy individuals. Each participant underwent ECG, echocardiographic, and blood pressure (BP) measurements. Conventional and new ECG indexes for cardiac OD (Tp-Te interval, ventricular activation time, and P-wave analysis) were also measured. Clinic and 24-hour ambulatory BP levels as well as left ventricular mass indexes were significantly higher in hypertensive than in normotensive patients. No significant differences were found between the two groups for ECG and echocardiographic markers of OD. Only Tp-Te interval was higher in hypertensive than in normotensive individuals (3.06 mm vs 2.24 mm; P<.0001), even after adjustment for anthropometric and clinical parameters. Preliminary results of this study demonstrated prolonged Tp-Te interval in newly diagnosed, untreated hypertensive outpatients compared with normotensive individuals.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2015        PMID: 25772633      PMCID: PMC8032148          DOI: 10.1111/jch.12522

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  39 in total

1.  T peak-Tend interval as an index of transmural dispersion of repolarization.

Authors:  C Antzelevitch
Journal:  Eur J Clin Invest       Date:  2001-07       Impact factor: 4.686

2.  Left ventricular hypertrophy and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe.

Authors:  M L Bots; Y Nikitin; J T Salonen; P C Elwood; S Malyutina; A Freire de Concalves; J Sivenius; A Di Carlo; P Lagiou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

3.  ECG detection of left ventricular hypertrophy: the simpler, the better?

Authors:  Philippe Gosse; Emilie Jan; Paul Coulon; Antoine Cremer; Georgios Papaioannou; Sunthareth Yeim
Journal:  J Hypertens       Date:  2012-05       Impact factor: 4.844

4.  Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.

Authors:  W B Kannel; T Gordon; W P Castelli; J R Margolis
Journal:  Ann Intern Med       Date:  1970-06       Impact factor: 25.391

5.  Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.

Authors:  R E Schmieder; P Martus; A Klingbeil
Journal:  JAMA       Date:  1996-05-15       Impact factor: 56.272

6.  Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial and the Telmisartan Randomized Assessment Study in ACE Intolerant Subjects With Cardiovascular Disease.

Authors:  Paolo Verdecchia; Peter Sleight; Giuseppe Mancia; Robert Fagard; Bruno Trimarco; Roland E Schmieder; Jae-Hyung Kim; Garry Jennings; Petr Jansky; Jyh-Hong Chen; Lisheng Liu; Peggy Gao; Jeffrey Probstfield; Koon Teo; Salim Yusuf
Journal:  Circulation       Date:  2009-09-21       Impact factor: 29.690

7.  Association between Tp-e/QT ratio and prognosis in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Authors:  Xiangmei Zhao; Zhouliang Xie; Yingjie Chu; Lei Yang; Wenkai Xu; Xianzhi Yang; Xiaoyu Liu; Lixiao Tian
Journal:  Clin Cardiol       Date:  2012-06-27       Impact factor: 2.882

8.  Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.

Authors:  P M Okin; R B Devereux; J E Liu; L Oikarinen; S Jern; S E Kjeldsen; S Julius; K Wachtell; M S Nieminen; B Dahlöf
Journal:  J Hum Hypertens       Date:  2004-06       Impact factor: 3.012

9.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  8 in total

1.  Obesity and hypertension contribute to prolong QRS complex duration among middle-aged adults.

Authors:  Dillon J Dzikowicz; Mary G Carey
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-05-29       Impact factor: 1.468

2.  Cuffless Blood Pressure Measurement Using Linear and Nonlinear Optimized Feature Selection.

Authors:  Mohammad Mahbubur Rahman Khan Mamun; Ali T Alouani
Journal:  Diagnostics (Basel)       Date:  2022-02-05

Review 3.  Conventional and new electrocardiographic criteria for hypertension-mediated cardiac organ damage: A narrative review.

Authors:  Francesca Miceli; Vivianne Presta; Barbara Citoni; Flaminia Canichella; Ilaria Figliuzzi; Andrea Ferrucci; Massimo Volpe; Giuliano Tocci
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-06       Impact factor: 3.738

4.  A Novel Electrocardiographic T-Wave Measurement (Tp-Te Interval) as a Predictor of Heart Abnormalities in Hypertension: A New Opportunity for First-Line Electrocardiographic Evaluation.

Authors:  Andrea Ferrucci; Flaminia Canichella; Allegra Battistoni; Francesca Palano; Pietro Francia; Giuseppino Massimo Ciavarella; Massimo Volpe; Giuliano Tocci
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-13       Impact factor: 3.738

5.  A New Electrocardiographic Marker of Hypertensive Cardiac Damage.

Authors:  Cesare Cuspidi; Marijana Tadic; Carla Sala
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-13       Impact factor: 3.738

6.  Electrocardiography for Assessment of Hypertensive Heart Disease: A New Role for an Old Tool.

Authors:  Giuseppe Mulè'; Emilio Nardi; Marco Guarneri; Santina Cottone
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-05-10       Impact factor: 3.738

7.  Assessment of Hypertension Using Clinical Electrocardiogram Features: A First-Ever Review.

Authors:  Kathleen Bird; Gabriel Chan; Huiqi Lu; Heloise Greeff; John Allen; Derek Abbott; Carlo Menon; Nigel H Lovell; Newton Howard; Wee-Shian Chan; Richard Ribon Fletcher; Aymen Alian; Rabab Ward; Mohamed Elgendi
Journal:  Front Med (Lausanne)       Date:  2020-12-04

Review 8.  Repolarization Heterogeneity: Beyond the QT Interval.

Authors:  Stuart B Prenner; Sanjiv J Shah; Jeffrey J Goldberger; Andrew J Sauer
Journal:  J Am Heart Assoc       Date:  2016-04-29       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.